{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:29:59Z","timestamp":1792715399277,"version":"4.5.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1097\/01.pap.0000201828.92719.f3","type":"journal-article","created":{"date-parts":[[2006,2,2]],"date-time":"2006-02-02T04:02:40Z","timestamp":1138852960000},"page":"8-15","source":"Crossref","is-referenced-by-count":182,"title":["p16 Expression in the Female Genital Tract and Its Value in Diagnosis"],"prefix":"10.1097","volume":"13","author":[{"given":"Ciaran J","family":"O'Neill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","article-title":"The INK 4a\/ARF locus and melanoma.","volume":"22","author":"Sharpless","year":"2003","journal-title":"Oncogene"},{"key":"R2-2-20210202","first-page":"1061","article-title":"The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis.","volume":"88","author":"Soufir","year":"2001","journal-title":"Bull Cancer"},{"key":"R3-2-20210202","first-page":"2704","article-title":"Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.","volume":"5","author":"Xing","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mrfmmm.2004.08.021","article-title":"INK4a\/ARF: a multifunctional tumor suppressor locus.","volume":"576","author":"Sharpless","year":"2005","journal-title":"Mutat Res"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1440-1827.1998.tb03954.x","article-title":"Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia.","volume":"48","author":"Sano","year":"1998","journal-title":"Pathol Int"},{"key":"R6-2-20210202","first-page":"1137","article-title":"Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues.","volume":"79","author":"Nielsen","year":"1999","journal-title":"Lab Invest"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.5149","article-title":"p16 (MTS-1\/CDKN2\/INK4a) in cancer progression.","volume":"264","author":"Rocco","year":"2001","journal-title":"Exp Cell Res"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0046-8177(97)90003-4","article-title":"Loss of Rb and MTS1\/CDKN2 (P16) expression in human sarcomas.","volume":"28","author":"Cohen","year":"1997","journal-title":"Hum Pathol"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/hupa.2002.130108","article-title":"CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.","volume":"33","author":"Vo","year":"2002","journal-title":"Hum Pathol"},{"key":"R10-2-20210202","first-page":"1062","article-title":"P16-INK4A is regularly expressed in Hodgkins disease: comparison with retinoblastoma, p53 and MDM2 protein status and the presence of EBV.","volume":"12","author":"Guenova","year":"1999","journal-title":"Mod Pathol"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/modpathol.3880444","article-title":"Agnantis, et al. Low expression of p27 protein combined with altered p53 and Rb\/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.","volume":"14","author":"Bai","year":"2001","journal-title":"Mod Pathol"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/hupa.2003.8","article-title":"The p16\/cyclin D1\/Rb pathway in neuroendocrine tumors of the lung.","volume":"34","author":"Beasley","year":"2003","journal-title":"Hum Pathol"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/path.1374","article-title":"Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays.","volume":"200","author":"Levrsha","year":"2003","journal-title":"J Pathol"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0002-9440(10)65689-1","article-title":"Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions.","volume":"153","author":"Sano","year":"1998","journal-title":"Am J Pathol"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","article-title":"Overexpression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.","volume":"92","author":"Klaes","year":"2001","journal-title":"Int J Cancer"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/00000478-200107000-00006","article-title":"Ki-67, cyclin E and p16 are complimentary surrogate biomarkers for human papillomavirus-related cervical neoplasia.","volume":"25","author":"Keating","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0002-9440(10)63871-0","article-title":"Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.","volume":"162","author":"Klussmann","year":"2003","journal-title":"Am J Pathol"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.MP.0000077417.08371.CE","article-title":"Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.","volume":"16","author":"Lu","year":"2003","journal-title":"Mod Pathol"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s004280100439","article-title":"Expression of cyclin-dependent kinase inhibitors p16, p21 and p27 in HPV-positive and HPV-negative cervical adenocarcinomas.","volume":"439","author":"Milde-Langosch","year":"2001","journal-title":"Virchows Arch"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.pas.0000155164.78785.c2","article-title":"p16 INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia.","volume":"29","author":"Kalof","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/modpathol.3800290","article-title":"Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents.","volume":"18","author":"Hu","year":"2005","journal-title":"Mod Pathol"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.humpath.2004.02.012","article-title":"Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.","volume":"35","author":"Tringler","year":"2004","journal-title":"Hum Pathol"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/00313020500058607","article-title":"p16 (INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.","volume":"37","author":"Dray","year":"2005","journal-title":"Pathology"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.MP.0000077518.78046.0C","article-title":"p16 (INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki67 expression and detection of high-risk HPV types.","volume":"16","author":"Agoff","year":"2003","journal-title":"Mod Pathol"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00428-004-1127-9","article-title":"p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.","volume":"445","author":"Negri","year":"2004","journal-title":"Virchows Arch"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1369\/jhc.4A6312.2005","article-title":"Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions.","volume":"53","author":"Guimaraes","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1309\/FB900YXTF7D2HE99","article-title":"Histologic and immunohistochemical characteristics of neoplastic and nonneoplastic subgroups of atypical squamous lesions of the uterine cervix.","volume":"123","author":"Aoyama","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jcp.49.10.833","article-title":"Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems.","volume":"49","author":"McCluggage","year":"1996","journal-title":"J Clin Pathol"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","article-title":"p16 INK 4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia.","volume":"26","author":"Klaes","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00128360-200504000-00006","article-title":"Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E and p16 immunohistochemical analysis.","volume":"9","author":"Qiao","year":"2005","journal-title":"J Low Genit Tract Dis"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2559.2002.01465.x","article-title":"Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.","volume":"41","author":"Cameron","year":"2002","journal-title":"Histopathology"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.PGP.0000055172.04957.2F","article-title":"Immunohistochemical staining with p16 may assist in the distinction between endometrial and endocervical adenocarcinoma.","volume":"22","author":"McCluggage","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/path.1480","article-title":"The presence of high-risk HPV combined with specific p53 and p16 INK 4 A expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.","volume":"201","author":"Zielinski","year":"2003","journal-title":"J Pathol"},{"key":"R34-2-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004347-199907000-00005","article-title":"Infrequent occurrence of high-risk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix.","volume":"18","author":"Toki","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R35-2-20210202","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/modpathol.3800148","article-title":"Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia\/pyloric gland metaplasia and adenoma malignum.","volume":"17","author":"Mikami","year":"2004","journal-title":"Mod Pathol"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.humpath.2004.08.015","article-title":"Cervical adenoid basal tumors comprised of adenoid basal epithelioma associated with various types of invasive carcinoma: clinicopathologic features, human papillomavirus DNA detection and p16 expression.","volume":"36","author":"Parwani","year":"2005","journal-title":"Hum Pathol"},{"key":"R37-2-20210202","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/00000478-200010000-00012","article-title":"Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?","volume":"24","author":"Park","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R38-2-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000478-200302000-00006","article-title":"p16 INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.","volume":"27","author":"Negri","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R39-2-20210202","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00428-004-1111-4","article-title":"p16INK4a positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.","volume":"445","author":"Murphy","year":"2004","journal-title":"Virchow Arch"},{"key":"R40-2-20210202","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/hupa.2002.127439","article-title":"Human papillomaviruses, expression of p16 and early endocervical glandular neoplasia.","volume":"33","author":"Riethdorf","year":"2002","journal-title":"Hum Pathol"},{"key":"R41-2-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004347-200201000-00001","article-title":"The fruits of our labors: distinguishing endometrial from endocervical adenocarcinoma.","volume":"21","author":"Zaino","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R42-2-20210202","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000478-200402000-00002","article-title":"Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.","volume":"28","author":"Ansari-Lari","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R43-2-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004347-200201000-00003","article-title":"A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin and estrogen receptor aids the distinction between primary endometrial and endocervical adenocarcinomas.","volume":"21","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R44-2-20210202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00004347-200201000-00002","article-title":"Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study.","volume":"21","author":"Castillon","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R45-2-20210202","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00000478-200407000-00009","article-title":"Detection of human papillomavirus DNA and expression of p16, Rb and p53 proteins in small cell carcinomas of the uterine cervix.","volume":"28","author":"Wang","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R46-2-20210202","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0046-8177(03)00284-3","article-title":"p16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.","volume":"34","author":"Masumoto","year":"2003","journal-title":"Hum Pathol"},{"key":"R47-2-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dc.20175","article-title":"p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus associated dysplasias of the uterine cervix as determined on the Pap smear.","volume":"32","author":"Bose","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"R48-2-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2004.11.034","article-title":"Is p16(INK4A) expression more useful than human papilloma virus test to determine the outcome of atypical squamous cells of uncertain significance-categorised Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.","volume":"97","author":"Nieh","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R49-2-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cncr.20046","article-title":"Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.","volume":"102","author":"Yoshida","year":"2004","journal-title":"Cancer"},{"key":"R50-2-20210202","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ijc.11589","article-title":"P16INK4a as an adjunct marker in liquid-based cervical cytology.","volume":"108","author":"Sahebali","year":"2004","journal-title":"Int J Cancer"},{"key":"R51-2-20210202","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.pgp.0000172083.94934.1e","article-title":"Abnormalities of the Rb1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16 (INK4a) protein.","volume":"24","author":"Armes","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"R52-2-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/gyno.1999.5629","article-title":"Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma.","volume":"75","author":"Zhai","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R53-2-20210202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2004.09.026","article-title":"Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.","volume":"96","author":"Bodner-Adler","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R54-2-20210202","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.pgp.0000130108.03231.89","article-title":"Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.","volume":"23","author":"Santos","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R55-2-20210202","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.humpath.2004.09.004","article-title":"p16 INK4A expression as biomarker for HPV16-related vulvar neoplasias.","volume":"35","author":"Riethdorf","year":"2004","journal-title":"Hum Pathol"},{"key":"R56-2-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000478-200003000-00013","article-title":"Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathological study including analysis of HPV and p53 expression.","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R57-2-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0046-8177(95)90030-6","article-title":"Vulvar intraepithelial neoplasia. Morphological phenotype, papillomavirus DNA and coexisting invasive carcinoma.","volume":"26","author":"Kaefner","year":"1995","journal-title":"Hum Pathol"},{"key":"R58-2-20210202","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1365-2559.2005.02036.x","article-title":"Simplex (differentiated) type VIN: absence of p16 INK4 supports its weak association with HPV and its probable precursor role in non-HPV related vulvar squamous cancers.","volume":"46","author":"Ruhul Quddus","year":"2005","journal-title":"Histopathology"},{"key":"R59-2-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO;2-F","article-title":"Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis.","volume":"74","author":"Dong","year":"1997","journal-title":"Int J Cancer"},{"key":"R60-2-20210202","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.pas.0000152136.81771.12","article-title":"Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.","volume":"29","author":"Elishaev","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R61-2-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.pas.0000166367.68459.7d","article-title":"An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas. Significantly higher expression of p53, MIB1, BCL2, HER-2\/neu and C-KIT in high-grade neoplasms.","volume":"29","author":"ONeill","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R62-2-20210202","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/path.1563","article-title":"A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes.","volume":"203","author":"Russell","year":"2004","journal-title":"J Pathol"},{"key":"R63-2-20210202","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"R64-2-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004347-200301000-00009","article-title":"Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma.","volume":"22","author":"Singer","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R65-2-20210202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00125480-200601000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:14:55Z","timestamp":1785856495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00125480-200601000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pap.0000201828.92719.f3","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}